Common Shares Outstanding: The number of class A shares currently held by investors.
PDS Biotechnology Corporation (PDSB) had Common Shares Outstanding of 104.21M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-7.62M |
|
-- |
|
-- |
|
$5.90M |
|
$-5.90M |
|
$-1.72M |
|
$-7.62M |
|
$-7.62M |
|
$-7.62M |
|
$-7.62M |
|
$-7.62M |
|
$-7.62M |
|
$-5.90M |
|
$-5.33M |
|
71.94M |
|
71.94M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$18.37M |
|
$0.17M |
|
$0.20M |
|
$18.57M |
|
$5.08M |
|
$0.00M |
|
$0.00M |
|
$5.08M |
|
$13.50M |
|
$13.50M |
|
$13.50M |
|
|
Common Shares Outstanding |
104.21M |
| Cash Flow Statement Financials | |
$-15.39M |
|
-- |
|
$3.92M |
|
$26.71M |
|
$15.25M |
|
$-11.47M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.62 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-56.47% |
|
-56.47% |
|
-41.03% |
|
-56.47% |
|
$0.13 |
|
$-0.21 |
|
$-0.21 |
|